Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.35 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.33 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.33 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28035948 | 0.83 | CHRM1 (0.50) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL3651519 | 0.78 | CHRM1 (0.52) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL967949 | 0.78 | CHRM1 (0.52) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL3652466 | 0.78 | CHRM1 (0.52) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| Ethane SCHEMBL29184108 | 0.76 | CHRM1 (0.50) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL4729539 | 0.76 | CHRM1 (0.50) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL30063957 | 0.76 | SLC1A3 (0.41) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL18765448 | 0.75 | TSHR (0.35) | TSHR | |
| SCHEMBL14110749 | 0.75 | TDP1 (0.60) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL5031485 | 0.75 | TDP1 (0.60) | CHRM1AKR1A1CHRM3HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0925792-B1 | Insoluble insulin compositions for controlling blood glucose | LILLY CO ELI (US) | 2004-04-21 | — | — | EP | disclosed |
| EP-1396272-A1 | Insoluble Insulin Compositions for Controlling Blood Glucose | Eli Lilly & Company (US) | 2004-03-10 | — | — | EP | disclosed |
| US-20030144181-A1 | Insoluble compositions for controlling blood glucose | BRADER MARK LAURENCE (US) | 2003-07-31 | — | — | US | disclosed |
| US-6531448-B1 | Composition comprising protein selected from insulin, insulin analog, and proinsulin; derivatized protein selected from fatty acid-acylated insulins; complexing compound; hexamer stabilizing compound; and divalent metal cation | ELI LILLY AND COMPANY | 2003-03-11 | — | — | US | disclosed |
| US-6465426-B2 | ACYLATION | ELI LILLY AND COMPANY | 2002-10-15 | — | — | US | disclosed |
| US-20020082199-A1 | Insoluble insulin compositions | BRADER MARK LAURENCE (US) | 2002-06-27 | — | — | US | disclosed |
| EP-1196445-A1 | INSULIN CRYSTALS FOR PULMONARY ADMINISTRATION | ELI LILLY AND COMPANY (US) | 2002-04-17 | — | — | EP | disclosed |
| EP-1173482-A1 | INSULIN CRYSTALS FOR PULMONARY ADMINISTRATION | ELI LILLY AND COMPANY (US) | 2002-01-23 | — | — | EP | disclosed |
| US-20010036916-A1 | Insoluble insulin compositions | BRADER MARK LAURENCE (US) | 2001-11-01 | — | — | US | disclosed |
| US-6268335-B1 | MICROCRYSTAL COMPRISING (A) DERIVIATED INSULIN, DERIVIATED INSULIN ANALOGS, OR DERIVIATED PROINSULINS; (B) A COMPLEXING COMPOUND; (C) A HEXAMER-STABILIZING COMPOUND; AND (D) A DIVALENT METAL CATION. | ELI LILLY AND COMPANY | 2001-07-31 | — | — | US | disclosed |
| WO-2001000674-A1 | INSULIN CRYSTALS FOR PULMONARY ADMINISTRATION | ELI LILLY AND COMPANY (US) | 2001-01-04 | — | — | WO | disclosed |
| WO-2000064940-A1 | INSULIN CRYSTALS FOR PULMONARY ADMINISTRATION | ELI LILLY AND COMPANY (US) | 2000-11-02 | — | — | WO | disclosed |
| EP-0925792-A2 | Insoluble compositions for controlling blood glucose | ELI LILLY AND COMPANY (US) | 1999-06-30 | — | — | EP | disclosed |
| WO-1999021578-A1 | INSOLUBLE INSULIN COMPOSITIONS | ELI LILLY AND COMPANY (US) | 1999-05-06 | — | — | WO | disclosed |
| EP-0911035-A2 | INSOLUBLE INSULIN COMPOSITIONS | ELI LILLY AND COMPANY (US) | 1999-04-28 | — | — | EP | disclosed |